PGNAX | RYBAX | PGNAX / RYBAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 35 years | 27 years | - |
Gain YTD | 4.576 | 5.395 | 85% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 674M | 25.8M | 2,612% |
Annual Yield % from dividends | 1.78 | 2.29 | 78% |
Returns for 1 year | 9.60 | 15.40 | 62% |
Returns for 3 years | 18.57 | 2.23 | 834% |
Returns for 5 years | 87.84 | 48.84 | 180% |
Returns for 10 years | 26.35 | 73.19 | 36% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HERSX | 10.31 | -0.03 | -0.29% |
Hartford Emerging Markets Equity R4 | |||
WDIIX | 13.82 | -0.07 | -0.50% |
Wilmington Enhanced Div Inc Strat I | |||
CSMEX | 27.06 | -0.15 | -0.55% |
Carillon Scout Mid Cap A | |||
GSILX | 20.73 | -0.16 | -0.77% |
Goldman Sachs GQG Ptnrs Intl Opps C | |||
ETHSX | 13.85 | -0.34 | -2.40% |
Eaton Vance Worldwide Health Sci A |